Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pulmonology
•
Obstructive Lung Disease
•
Asthma
What is your approach to inhaler therapy in a patient with asthma who cannot be on an inhaled corticosteroid due to ocular disease?
Answer from: at Academic Institution
I use LABA/LAMA combination.
Sign in or Register to read more
20609
Related Questions
What factors do you consider prior to offering a trial of ICS/LABA therapy versus a methacholine challenge test in patients with suspected asthma but normal pulmonary function testing?
Is methacholine challenge on its way out?
What is your approach to switching from one biologic agent to another in allergic asthma/type II inflammation?
Is there a role for biologics to improve lung function in patients who have severe asthma with daily symptoms and reduced lung function but do not experience frequent exacerbations?
Have you implemented the Rome proposal for COPD exacerbations?
Are the results of the BOREAS trial generalizable to non-white populations?
What patient factors prompt you to consider starting dupilumab in patients with COPD?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
Do you utilize the bronchiectasis severity index (BSI) in your approach to managing non-CF bronchiectasis?
Did the low rate of COPD exacerbations in the BOREAS cohort overall confound the results of the study?